1,2-dimethylhydrazine decreases expression ISO RGD:733045 6480464 1, 2-Dimethylhydrazine results in decreased expression of FGFR3 mRNA CTD PMID:22206623 1,3,5-trinitro-1,3,5-triazinane increases expression EXP 6480464 cyclonite results in increased expression of FGFR3 mRNA CTD PMID:25559034 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:733044 6480464 Dinitrochlorobenzene binds to FGFR3 protein CTD PMID:32991956 17alpha-ethynylestradiol affects expression ISO RGD:733044 6480464 Ethinyl Estradiol affects the expression of FGFR3 mRNA CTD PMID:20170705 17alpha-ethynylestradiol decreases expression ISO RGD:733044 6480464 Ethinyl Estradiol results in decreased expression of FGFR3 mRNA CTD PMID:18936297 17beta-estradiol multiple interactions ISO RGD:733045 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of FGFR3 mRNA] CTD PMID:25210133 17beta-estradiol multiple interactions ISO RGD:733044 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of FGFR3 mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of FGFR3 mRNA CTD PMID:20404318 , PMID:30165855 17beta-estradiol increases expression ISO RGD:733044 6480464 Estradiol results in increased expression of FGFR3 mRNA alternative form CTD PMID:14602803 17beta-estradiol increases expression ISO RGD:733045 6480464 Estradiol results in increased expression of FGFR3 mRNA CTD PMID:25210133 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733045 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FGFR3 mRNA, Tetrachlorodibenzodioxin affects the reaction [AHR protein binds to FGFR3 promoter] CTD PMID:19654925 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FGFR3 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FGFR3 mRNA CTD PMID:16960034 more ... 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of FGFR3 mRNA CTD PMID:23537331 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:733045 6480464 tetrabromobisphenol A results in decreased expression of FGFR3 mRNA CTD PMID:25172293 3,3',5-triiodo-L-thyronine increases expression ISO RGD:733045 6480464 Triiodothyronine results in increased expression of FGFR3 mRNA CTD PMID:16150908 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733044 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FGFR3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FGFR3 mRNA CTD PMID:28628672 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733045 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR3 mRNA CTD PMID:31009676 4,4'-sulfonyldiphenol increases expression ISO RGD:733044 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FGFR3 mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol multiple interactions ISO RGD:733044 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FGFR3 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:733045 6480464 Fenretinide results in increased expression of FGFR3 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FGFR3 mRNA CTD PMID:24780913 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of FGFR3 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:733044 6480464 Acrylamide results in decreased expression of FGFR3 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:733044 6480464 Aflatoxin B1 results in decreased expression of FGFR3 mRNA CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:733044 6480464 aflatoxin B2 results in increased methylation of FGFR3 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:733044 6480464 Tretinoin results in decreased expression of FGFR3 mRNA CTD PMID:23830798 , PMID:7680553 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FGFR3 mRNA CTD PMID:16483693 antimonite multiple interactions ISO RGD:733044 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FGFR3 mRNA CTD PMID:32076005 arachidonic acid decreases expression ISO RGD:733044 6480464 Arachidonic Acid results in decreased expression of FGFR3 mRNA CTD PMID:16704987 arsane multiple interactions ISO RGD:733044 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FGFR3 mRNA CTD PMID:32525701 arsane affects methylation ISO RGD:733044 6480464 Arsenic affects the methylation of FGFR3 gene CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:733044 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FGFR3 mRNA CTD PMID:32525701 arsenic atom affects methylation ISO RGD:733044 6480464 Arsenic affects the methylation of FGFR3 gene CTD PMID:25304211 arsenite(3-) multiple interactions ISO RGD:733044 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of FGFR3 mRNA CTD PMID:32076005 benzo[a]pyrene multiple interactions ISO RGD:733045 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to FGFR3 promoter] CTD PMID:19654925 benzo[a]pyrene increases methylation ISO RGD:733044 6480464 Benzo(a)pyrene results in increased methylation of FGFR3 5' UTR, Benzo(a)pyrene results in increased methylation of FGFR3 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:733044 6480464 Benzo(a)pyrene results in decreased expression of FGFR3 mRNA CTD PMID:22316170 , PMID:26238291 benzo[b]fluoranthene increases expression ISO RGD:733045 6480464 benzo(b)fluoranthene results in increased expression of FGFR3 mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide decreases expression ISO RGD:733044 6480464 Mustard Gas results in decreased expression of FGFR3 mRNA CTD PMID:16173061 bis(2-chloroethyl) sulfide decreases expression ISO RGD:733045 6480464 Mustard Gas results in decreased expression of FGFR3 mRNA CTD PMID:16377760 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:733045 6480464 Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of FGFR3 mRNA] CTD PMID:16377760 bisphenol A affects expression ISO RGD:733044 6480464 bisphenol A affects the expression of FGFR3 mRNA CTD PMID:20170705 , PMID:30903817 bisphenol A decreases methylation ISO RGD:733044 6480464 bisphenol A results in decreased methylation of FGFR3 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:733045 6480464 bisphenol A results in increased expression of FGFR3 mRNA CTD PMID:34585602 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FGFR3 mRNA CTD PMID:30816183 bisphenol A multiple interactions ISO RGD:733044 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FGFR3 mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FGFR3 mRNA CTD PMID:25181051 butan-1-ol multiple interactions ISO RGD:733044 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FGFR3 mRNA CTD PMID:29432896 butanal decreases expression ISO RGD:733044 6480464 butyraldehyde results in decreased expression of FGFR3 mRNA CTD PMID:26079696 caffeine increases phosphorylation ISO RGD:733044 6480464 Caffeine results in increased phosphorylation of FGFR3 protein CTD PMID:35688186 calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of FGFR3 protein CTD PMID:15728789 carbon nanotube decreases expression ISO RGD:733045 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chlordecone increases expression ISO RGD:733045 6480464 Chlordecone results in increased expression of FGFR3 mRNA CTD PMID:33711761 chlorthalidone decreases expression EXP 6480464 Chlorthalidone results in decreased expression of FGFR3 mRNA CTD PMID:20625077 chrysene increases expression ISO RGD:733045 6480464 chrysene results in increased expression of FGFR3 mRNA CTD PMID:26377693 cisplatin increases expression ISO RGD:733044 6480464 Cisplatin results in increased expression of FGFR3 mRNA CTD PMID:12066199 , PMID:27392435 cisplatin multiple interactions ISO RGD:733044 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of FGFR3 mRNA CTD PMID:27392435 copper atom multiple interactions ISO RGD:733044 6480464 [Chelating Agents binds to Copper] which results in increased expression of FGFR3 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:733044 6480464 [Chelating Agents binds to Copper] which results in increased expression of FGFR3 mRNA CTD PMID:30911355 copper(II) sulfate decreases expression ISO RGD:733044 6480464 Copper Sulfate results in decreased expression of FGFR3 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:733044 6480464 Cyclosporine results in decreased expression of FGFR3 mRNA CTD PMID:20106945 more ... dexamethasone decreases response to substance ISO RGD:733045 6480464 FGFR3 protein results in decreased susceptibility to Dexamethasone CTD PMID:12393593 dexamethasone multiple interactions ISO RGD:733045 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR3 mRNA CTD PMID:31009676 dexamethasone multiple interactions ISO RGD:733044 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FGFR3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FGFR3 mRNA CTD PMID:28628672 diazinon increases methylation ISO RGD:733044 6480464 Diazinon results in increased methylation of FGFR3 gene CTD PMID:22964155 dibenz[a,h]anthracene increases expression ISO RGD:733045 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FGFR3 mRNA CTD PMID:21266533 dimercaprol multiple interactions ISO RGD:733045 6480464 Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of FGFR3 mRNA] CTD PMID:16377760 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:733044 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FGFR3 mRNA CTD PMID:32076005 dorsomorphin multiple interactions ISO RGD:733044 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:733045 6480464 Doxorubicin results in increased expression of FGFR3 mRNA CTD PMID:25896364 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FGFR3 mRNA CTD PMID:29391264 endosulfan decreases expression ISO RGD:733044 6480464 Endosulfan results in decreased expression of FGFR3 mRNA CTD PMID:30090376 entinostat increases expression ISO RGD:733044 6480464 entinostat results in increased expression of FGFR3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:733044 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR3 mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:733044 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FGFR3 mRNA CTD PMID:29432896 ethanol increases expression ISO RGD:733045 6480464 Ethanol results in increased expression of FGFR3 mRNA CTD PMID:30319688 ethanol affects splicing ISO RGD:733045 6480464 Ethanol affects the splicing of FGFR3 mRNA CTD PMID:30319688 fenamidone increases expression ISO RGD:733045 6480464 fenamidone results in increased expression of FGFR3 mRNA CTD PMID:27029645 genistein increases expression ISO RGD:733044 6480464 Genistein results in increased expression of FGFR3 mRNA CTD PMID:22228119 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of FGFR3 mRNA CTD PMID:33387578 gossypol decreases expression ISO RGD:733044 6480464 Gossypol results in decreased expression of FGFR3 mRNA CTD PMID:19825521 gossypol multiple interactions ISO RGD:733044 6480464 zoledronic acid promotes the reaction [Gossypol results in decreased expression of FGFR3 mRNA] CTD PMID:19825521 heparan sulfate increases activity ISO RGD:733045 6480464 Heparitin Sulfate analog results in increased activity of FGFR3 protein alternative form CTD PMID:12460940 heparin affects activity ISO RGD:733045 6480464 Heparin affects the activity of FGFR3 protein CTD PMID:1379594 heparin multiple interactions ISO RGD:733045 6480464 Heparin promotes the reaction [FGFR3 protein binds to FGF1 protein] CTD PMID:1379594 hydrogen chloride increases expression ISO RGD:733044 6480464 Hydrochloric Acid results in increased expression of FGFR3 mRNA CTD PMID:15046208 hydroquinone decreases expression ISO RGD:733044 6480464 hydroquinone results in decreased expression of FGFR3 mRNA CTD PMID:31256213 hydroquinone O-beta-D-glucopyranoside decreases expression ISO RGD:733044 6480464 Arbutin results in decreased expression of FGFR3 mRNA CTD PMID:17103032 indometacin multiple interactions ISO RGD:733044 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FGFR3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FGFR3 mRNA CTD PMID:28628672 isobutanol multiple interactions ISO RGD:733044 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FGFR3 mRNA CTD PMID:29432896 isoprenaline increases expression ISO RGD:733045 6480464 Isoproterenol results in increased expression of FGFR3 mRNA CTD PMID:20003209 isotretinoin increases expression ISO RGD:733044 6480464 Isotretinoin results in increased expression of FGFR3 mRNA CTD PMID:20436886 ketamine increases expression EXP 6480464 Ketamine results in increased expression of FGFR3 mRNA CTD PMID:20080153 kojic acid decreases expression ISO RGD:733044 6480464 kojic acid results in decreased expression of FGFR3 mRNA CTD PMID:16595896 lead(0) affects expression ISO RGD:733044 6480464 Lead affects the expression of FGFR3 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:733044 6480464 Lead affects the expression of FGFR3 mRNA CTD PMID:28903495 lenalidomide decreases expression ISO RGD:733044 6480464 Lenalidomide results in decreased expression of FGFR3 mRNA CTD PMID:30834740 Licochalcone B increases expression ISO RGD:733044 6480464 licochalcone B results in increased expression of FGFR3 mRNA CTD PMID:33647349 maneb multiple interactions ISO RGD:733045 6480464 [Maneb co-treated with Paraquat] results in increased expression of FGFR3 mRNA, Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of FGFR3 mRNA] CTD PMID:23963992 masitinib decreases activity ISO RGD:733044 6480464 masitinib results in decreased activity of FGFR3 protein CTD PMID:19789626 metacetamol decreases expression ISO RGD:733045 6480464 3-hydroxyacetanilide results in decreased expression of FGFR3 mRNA CTD PMID:18544908 methamphetamine increases expression ISO RGD:733045 6480464 Methamphetamine results in increased expression of FGFR3 mRNA CTD PMID:26307267 methylmercury chloride increases expression ISO RGD:733044 6480464 methylmercuric chloride results in increased expression of FGFR3 mRNA CTD PMID:23179753 , PMID:26272509 methylmercury chloride multiple interactions ISO RGD:733044 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR3 mRNA CTD PMID:27188386 midostaurin decreases activity ISO RGD:733044 6480464 midostaurin results in decreased activity of FGFR3 protein CTD PMID:16091734 mono(2-ethylhexyl) phthalate increases expression ISO RGD:733045 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of FGFR3 mRNA CTD PMID:31009676 nitrofen increases expression ISO RGD:733045 6480464 nitrofen results in increased expression of FGFR3 mRNA CTD PMID:9859898 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of FGFR3 mRNA CTD PMID:20638522 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of FGFR3 mRNA, nitrofen results in increased expression of FGFR3 protein CTD PMID:21994076 ozone multiple interactions ISO RGD:733045 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FGFR3 mRNA CTD PMID:34911549 panobinostat multiple interactions ISO RGD:733044 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR3 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:733044 6480464 panobinostat results in increased expression of FGFR3 mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:733045 6480464 Acetaminophen results in decreased expression of FGFR3 mRNA CTD PMID:18544908 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FGFR3 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:733044 6480464 Acetaminophen results in increased expression of FGFR3 mRNA CTD PMID:22230336 paraquat multiple interactions ISO RGD:733045 6480464 [Maneb co-treated with Paraquat] results in increased expression of FGFR3 mRNA, Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of FGFR3 mRNA] CTD PMID:23963992 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23829299 PD173074 decreases activity ISO RGD:733044 6480464 PD 173074 results in decreased activity of FGFR3 protein CTD PMID:15029211 pentane-2,3-dione decreases expression EXP 6480464 2, 3-pentanedione results in decreased expression of FGFR3 mRNA CTD PMID:25710175 perfluorooctane-1-sulfonic acid affects expression ISO RGD:733045 6480464 perfluorooctane sulfonic acid affects the expression of FGFR3 mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression ISO RGD:733045 6480464 perfluorooctanoic acid affects the expression of FGFR3 mRNA CTD PMID:19429403 pirinixic acid multiple interactions ISO RGD:733044 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FGFR3 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:733045 6480464 pirinixic acid results in decreased expression of FGFR3 mRNA CTD PMID:20813756 , PMID:23811191 pomalidomide affects expression ISO RGD:733044 6480464 pomalidomide affects the expression of FGFR3 mRNA CTD PMID:30834740 ponatinib decreases activity ISO RGD:733044 6480464 ponatinib analog results in decreased activity of FGFR3 protein, ponatinib results in decreased activity of FGFR3 protein CTD PMID:19878872 , PMID:21561767 propiconazole decreases expression ISO RGD:733045 6480464 propiconazole results in decreased expression of FGFR3 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:733044 6480464 Quercetin results in decreased expression of FGFR3 mRNA CTD PMID:21632981 resveratrol decreases expression ISO RGD:733045 6480464 resveratrol results in decreased expression of FGFR3 mRNA CTD PMID:23525482 retinyl acetate increases expression ISO RGD:733045 6480464 retinol acetate results in increased expression of FGFR3 mRNA CTD PMID:16772331 SB 431542 multiple interactions ISO RGD:733044 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sildenafil citrate increases expression EXP 6480464 Sildenafil Citrate results in increased expression of FGFR3 mRNA CTD PMID:20583517 silicon dioxide decreases expression ISO RGD:733044 6480464 Silicon Dioxide analog results in decreased expression of FGFR3 mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:733044 6480464 Silver results in decreased expression of FGFR3 mRNA CTD PMID:26014281 silver(0) decreases expression ISO RGD:733044 6480464 Silver results in decreased expression of FGFR3 mRNA CTD PMID:26014281 sodium arsenate multiple interactions ISO RGD:733044 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FGFR3 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:733044 6480464 sodium arsenite results in decreased expression of FGFR3 mRNA CTD PMID:29301061 sodium arsenite increases expression ISO RGD:733044 6480464 sodium arsenite results in increased expression of FGFR3 mRNA CTD PMID:34032870 sodium arsenite multiple interactions ISO RGD:733044 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of FGFR3 mRNA CTD PMID:32076005 sulforaphane decreases expression ISO RGD:733044 6480464 sulforaphane results in decreased expression of FGFR3 mRNA CTD PMID:31838189 tamoxifen decreases expression ISO RGD:733045 6480464 Tamoxifen results in decreased expression of FGFR3 mRNA CTD PMID:25123088 tanespimycin multiple interactions ISO RGD:733044 6480464 tanespimycin results in increased degradation of and results in decreased expression of FGFR3 protein CTD PMID:16061882 temozolomide increases expression ISO RGD:733044 6480464 Temozolomide results in increased expression of FGFR3 mRNA CTD PMID:31758290 testosterone increases expression ISO RGD:733045 6480464 Testosterone results in increased expression of FGFR3 mRNA CTD PMID:7536664 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FGFR3 mRNA CTD PMID:16644059 thalidomide affects expression ISO RGD:733044 6480464 Thalidomide affects the expression of FGFR3 mRNA CTD PMID:30834740 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of FGFR3 mRNA CTD PMID:34492290 triacsin C decreases expression ISO RGD:733044 6480464 triacsin C results in decreased expression of FGFR3 mRNA CTD PMID:16704987 trichostatin A increases expression ISO RGD:733044 6480464 trichostatin A results in increased expression of FGFR3 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:733044 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR3 mRNA CTD PMID:27188386 triptonide increases expression ISO RGD:733045 6480464 triptonide results in increased expression of FGFR3 mRNA CTD PMID:33045310 urethane increases expression ISO RGD:733044 6480464 Urethane results in increased expression of FGFR3 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:733044 6480464 Valproic Acid affects the expression of FGFR3 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:733044 6480464 Valproic Acid results in decreased expression of FGFR3 mRNA CTD PMID:23179753 more ... valproic acid increases methylation ISO RGD:733044 6480464 Valproic Acid results in increased methylation of FGFR3 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:733044 6480464 Valproic Acid results in increased expression of FGFR3 mRNA CTD PMID:19101580 , PMID:24935251 vancomycin increases expression ISO RGD:733045 6480464 Vancomycin results in increased expression of FGFR3 mRNA CTD PMID:18930951 vorinostat decreases expression ISO RGD:733044 6480464 vorinostat results in decreased expression of FGFR3 mRNA CTD PMID:27188386 zoledronic acid multiple interactions ISO RGD:733044 6480464 zoledronic acid promotes the reaction [Gossypol results in decreased expression of FGFR3 mRNA] CTD PMID:19825521 zoledronic acid decreases expression ISO RGD:733044 6480464 zoledronic acid results in decreased expression of FGFR3 mRNA CTD PMID:24714768
